Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Conference item |
| Мова: | English |
| Опубліковано: |
Journal of Rheumatology
2022
|
| _version_ | 1826309003462836224 |
|---|---|
| author | Taylor, P Takeuchi, T Burmester, G Durez, P Smolen, J Deberdt, W Zhong, J Teres, JR Bello, N Winthrop, K Pope, J |
| author_facet | Taylor, P Takeuchi, T Burmester, G Durez, P Smolen, J Deberdt, W Zhong, J Teres, JR Bello, N Winthrop, K Pope, J |
| author_sort | Taylor, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T07:29:15Z |
| format | Conference item |
| id | oxford-uuid:aa10c1dd-308b-4f9c-b12e-f7f7c5ebeba3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:29:15Z |
| publishDate | 2022 |
| publisher | Journal of Rheumatology |
| record_format | dspace |
| spelling | oxford-uuid:aa10c1dd-308b-4f9c-b12e-f7f7c5ebeba32022-12-09T17:19:14ZSafety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysisConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:aa10c1dd-308b-4f9c-b12e-f7f7c5ebeba3EnglishSymplectic ElementsJournal of Rheumatology2022Taylor, PTakeuchi, TBurmester, GDurez, PSmolen, JDeberdt, WZhong, JTeres, JRBello, NWinthrop, KPope, J |
| spellingShingle | Taylor, P Takeuchi, T Burmester, G Durez, P Smolen, J Deberdt, W Zhong, J Teres, JR Bello, N Winthrop, K Pope, J Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis |
| title | Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis |
| title_full | Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis |
| title_fullStr | Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis |
| title_full_unstemmed | Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis |
| title_short | Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis |
| title_sort | safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9 3 years an updated integrated safety analysis |
| work_keys_str_mv | AT taylorp safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT takeuchit safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT burmesterg safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT durezp safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT smolenj safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT deberdtw safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT zhongj safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT teresjr safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT bellon safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT winthropk safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis AT popej safetyprofileofbaricitinibforthetreatmentofrheumatoidarthritisupto93yearsanupdatedintegratedsafetyanalysis |